Accessibility Menu
 
C21 Investments logo

C21 Investments

(OTC) CXXIF

Current Price$0.30
Market Cap$67.59M
Since IPO (2011)+24%
5 Year-71%
1 Year+91%
1 Month+20%

C21 Investments Financials at a Glance

Market Cap

$67.59M

Revenue (TTM)

$33.40M

Net Income (TTM)

$3.44M

EPS (TTM)

$-0.03

P/E Ratio

-10.69

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$0.30

Volume

150

Open

$0.30

Previous Close

$0.31

Daily Range

$0.30 - $0.30

52-Week Range

$0.13 - $0.54

CXXIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About C21 Investments

Industry

Pharmaceuticals

Employees

110

CEO

Sonny Newman

Headquarters

Vancouver, BC V6B 1G1, CA

CXXIF Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

8%

Net Income Margin

-10%

Return on Equity

-12%

Return on Capital

5%

Return on Assets

-6%

Earnings Yield

-9.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$67.59M

Shares Outstanding

218.04M

Volume

150

Avg. Volume

177.24K

Financials (TTM)

Gross Profit

$13.11M

Operating Income

$2.62M

EBITDA

$4.56M

Operating Cash Flow

$1.44M

Capital Expenditure

$133.80K

Free Cash Flow

$1.31M

Cash & ST Invst.

$2.42M

Total Debt

$10.95M

C21 Investments Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$8.27M

+4.5%

Gross Profit

$2.71M

-25.4%

Gross Margin

32.82%

N/A

Market Cap

$67.59M

N/A

Market Cap/Employee

$592.92K

N/A

Employees

114

N/A

Net Income

$620.13K

-373.4%

EBITDA

$969.67K

-34.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Net Cash

$8.53M

+22.3%

Accounts Receivable

$967.45K

+385.1%

Inventory

$4.26M

+9.6%

Long Term Debt

$9.31M

-14.6%

Short Term Debt

$1.64M

-36.4%

Return on Assets

-6.26%

N/A

Return on Invested Capital

5.41%

N/A

Free Cash Flow

$77.03K

-108.8%

Operating Cash Flow

$21.90K

-102.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VEXTFVext Science, Inc.
$0.26-2.45%
MRMDMariMed Inc.
$0.09-0.50%
ELIXFElixxer Ltd.
$0.03+0.00%
TCNAFTransCanna Holdings Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$9.30+3.02%
NOKNokia
$13.44+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.22+0.01%
NCLHNorwegian Cruise Line
$17.12-0.09%

Questions About CXXIF

What is the current price of C21 Investments?

C21 Investments is trading at $0.30 per share.

What is the 52-week range for C21 Investments?

Over the past 52 weeks, C21 Investments has traded between $0.13 and $0.54.

How much debt does C21 Investments have?

As of the most recent reporting period, C21 Investments reported total debt of $10.95M.

How much cash does C21 Investments have on hand?

C21 Investments reported $2.42M in cash and cash equivalents in its most recent financial results.

What is C21 Investments’s dividend yield?

C21 Investments does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.